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Abstract. The demography of treatment of children by
renal replacement therapy in Europe is presented based on
returns of individual patient questionnaires to the EDTA
Registry up until the close of 1984. Patient questionnaires
for 1984 were completed by all centres which defined them-
selves as special paediatric units. A total of 4983 patients
have been reported to the Registry up until 31 December
1984 as having commenced renal replacement therapy
under the age of 15. Of these, 1570 were known to be alive
on a defined form of treatment at the end of 1984 and still
under the age of 15. The numbers of these patients kept
alive by different forms of treatment in individual countries
are presented. The stock of patients aged under 15 at the
end of 1984 exceeded 30 per million child population in
Belgium, France, Iceland and Luxembourg. The highest age
specific acceptance rates for children onto renal replace-
ment therapy during 1984 were noted in those aged between
10 and 14 at first treatment. Age specific acceptance rates
for children varied greatly between individual countries,
and 18 countries reported no new patients under the age of
5 during 1984. Transplant activity in paediatric patients
during 1984 has been analysed and results on regrafting pre-
sented. Proportional distribution of primary renal diseases
amongst children commencing therapy in 1984 is shown
according to age at start of treatment. Haemolytic uraemic
syndrome was reported as the cause of end-stage renal
failure in 12.0% of children commencing treatment under
the age of 5, and 12.3% of children between 5 and 9.
Finally, information on cause of death in paediatric patients
dying during 1984 is presented, and shows cardiovascular
disease was the leading cause of mortality.
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Introduction
The Registry of the European Dialysis and Transplant
Association—European Renal Association (EDTA
Registry) has regularly presented data on children treated by
renal replacement therapy since 1972 and has published a
series of 14 Combined Reports on Regular Dialysis and
Transplantation in Children in Europe in the Proceedings of
the EDTA-ERA. The last of these appeared in 1985 [1].
This report on treatment of children, the first to be pre-
pared by the Registry for the new journal, is based exclus-
ively on data provided on individual patient questionnaires
and relates to treatment up until 31 December 1984. Ana-
lyses were carried out on the Registry's files at the time of
the preprinting of the 1985 questionnaires, the point in the
Registry's annual cycle when the data base is in its best
form.
Report from the EDTA Registry
paediatric centres. Patient questionnaires for 1984 were
returned by all of these 97 units.
Up to 31 December 1984, 4983 patients were reported
to the Registry as having commenced renal replacement
therapy under the age of 15. Of these, 3405 were alive on
a known method of treatment and 1570 were under the age
of 15 (Table 1).
Table 2 shows the stock of patients aged under 15 on 31
December 1984, alive on a known form of renal replace-
ment therapy. Both absolute numbers and total per million
child population (PMCP) are given. Data on child popu-
lation were obtained from the WHO Statistics Annual using
the most up to date information available for each country.
Age and sex specific acceptance rates for children onto
renal replacement therapy in 1984 are given by country in
Table 3. An age-sex specific rate is calculated by dividing
the number of new patients in each age and sex category by
the total number of children in the general population of the
Methods: the Paediatric Registry data base
All patients who commence renal replacement therapy
under the age of 15 are defined as paediatric. In the year
of any particular report, many of these will have reached
adult age, and so the word 'children' has been adopted to
describe patients who commence therapy under 15 and who
are still under that age on 31 December in the year under
consideration.
Patient questionnaires completed on children are handled
in the same way as those for adults, and the Registry's main
patient file contains data on all individually registered
patients irrespective of age at start of treatment. The infor-
mation collected and the method of handling forms and
notification of new centres are described in the preceding
paper. A distinction between children and adult patients is
only made at the time analyses are carried out. A special
paediatric file has been created to link data from individual
patient questionnaires on children to those obtained from
the special paediatric enquiry which goes out to selected
centres each year. Information from the special file is not
included in this report.
Results: demographic statistics
Children may be treated in either non-specialised or
specialised paediatric centres. These are self-defined on
the Registry's centre questionnaire. The completeness of the
paediatric survey for 1984 may be assessed from Table 1 of
the general demographic article which precedes this. This
shows the total number of centres known in countries
reporting to the Registry and the proportion which
returned patient questionnaires for 1984. In the 1984 centre
questionnaire, 97 units defined themselves as specialised
Table 1. Summary of patients reported to the Registry who commenced
renal replacement therapy under 15 years of age. Total number, number
alive at the end of 1984, and number known to be alive at the end of 1984
still aged under IS are given
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total number
of paediatric
patients
14
68
174
45
5
35
79
22
685
38
966
127
61
16
2
37
101
540
4
10
8
1
207
52
98
51
467
81
85
6
33
761
104
Paediatric
patients alive
31 Dec. 1984
10
45
136
14
3
14
45
12
491
31
714
72
18
9
2
26
66
341
1
2
4
1
153
40
47
35
347
60
63
4
13
537
49
Paediatric
patients alive
31 Dec. 1984
aged 0-14 years
9
19
78
8
0
8
18
9
194
11
348
33
6
6
2
11
31
156
0
0
3
1
67
16
29
.23
183
23
24
2
9
218
25
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Table 2. Stock of children alive on 31 December 1984 in individual countries. Numbers on different forms of
renal replacement therapy given together with the total number per million child population (PMCP)
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Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Patients on
Hosp. HD
7
11
18
8
0
4
7
6
66
2
175
26
2
1
2
3
5
88
0
0
1
0
21
1
19
19
106
2
6
1
9
45
23
treatment at 31
Home HD
0
0
0
0
0
0
0
0
4
0
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
5
0
December
IPD
0
0
1
0
0
0
1
0
8
0
0
0
0
1
0
0
0
4
0
0
0
0
0
0
3
0
6
1
"0
0
0
1
0
1984
CAPD
1
1
3
0
0
0
3
0
19
2
16
0
2
0
0
2
8
20
0
0
0
0
15
0
4
2
15
3
5
1
0
49
0
Graft
1
7
56
0
0
4
7
3
97
7
151
7
2
4
0
6
18
44
0
0
2
1
31
15
3
2
52
17
13
0
0
118
2
Total
9
19
78
8
0
8
18
9
194
11
348
33
6
6
2
11
31
156
0
0
3
1
67
16
29
23
183
23
24
2
9
218
25
PMCP
1.6
12.6
39.0
4.1
0
2.2
17.4
0.6
18.0
11.3
30.2
10.0
2.8
2.5
31.8
10.8
24.1
11.9
0
0
43.5
0.1
21.6
17.9
3.4
8.4
18.8
14.4
19.6
0.8
0.5
18.9
4.6
same age and sex. The data are given for three age groups,
those aged between 0 and 4 years at first treatment, those
aged 5-9, and finally, those aged 10-14. Acceptance rates
are shown separately for males and females in each age
category. The table also gives the total number of children
who commenced replacement therapy in 1984. This figure
will include children whose sex was not registered. There
were a total of 522 new paediatric patients in 1984.
Transplantation activity during 1984 in children is
summarised in Table 4. This divides the grafts according
to source, live donor or cadaver, and shows the numbers
which were first, second or third grafts. A total of 353 grafts
in children were reported in 1984. Table 4 shows the graft
according to the country where the child was last registered.
This does not necessarily indicate where the transplant was
performed.
The proportional distribution of primary renal diseases
leading to end-stage renal failure amongst children com-
mencing renal replacement therapy in 1984 is given in
Table 5. The results are shown according to age at start
of treatment for three age categories. Among 75 children
who commenced treatment under the age of 5 in 1984,
glomerulonephritis was the most common primary renal
disease diagnosed. Haemolytic uraemic syndrome accounted
for a further 12.0% of primary renal diseases in this age
group. In children aged 5-9 years at first treatment,
glomerulonephritis accounted for 17.2% of primary renal
diseases, whereas pyelonephritis/interstitial nephritis was
the diagnosis in just over a quarter of cases. Haemolytic
uraemic syndrome accounted for a further 12.3%. In the
oldest of the three age categories, glomerulonephritis was
the primary renal disease diagnosed in 32.4% of children,
while pyelonephritis/interstitial nephritis was reported in
29.8%.
Table 6 shows cause of death in patients who died in 1984
under the age of 15. There were a total of 62 deaths and
both the absolute number for each of 46 different causes
and their proportional distribution are given. The most
common cause of death was cardiac arrest, cause unknown,
which accounted for 14.5% of mortality. As a group, car-
diac causes were the most common, accounting for almost
half the deaths. Infection was reported as cause of death in
12
Table 3. Age and sex specific acceptance rates for male and female children commencing renal replacement
therapy in 1984. Acceptance rates are given by sex for three age groups. Total number of children commencing
therapy in 1984 also given
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Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Acceptance rates 1984 PMCP according to age at start of treatment
0-4
Male
0
0
3.1
0
0
0
0
0
3.9
0
3.1
4.2
0
0
0
0
4.2
3.7
0
0
0
0
8.4
0
0.6
0
7.2
7.2
0
0
0
3.1
2.1
Female
0
0
3.2
0
0
0
0
0
2.0
0
4.9
2.2
0
0
0
6.1
0
0.5
0
0
0
0
0
7.1
0.7
2.3
7.0
3.8
0
0
0
0.6
1.1
5-9
Male
1.1
6.6
3.0
0
0
0
0
0
2.8
5.8
7.0
5.1
2.6
0
0
11.8
0
1.3
0
0
0
0
1.6
5.9
3.0
2.2
3.6
0
4.4
0
0
3.5
2.2
Female
0
0
11.5
0
0
0
0
0.5
2.4
0
6.3
12.5
0
0
0
6.2
0
4.6
0
0
0
0
6.9
0
3.1
0
3.2
14.4
9.3
0
0
3.7
0
10-14
Male
2.4
3.0
29.7
6.3
0
5.3
19.4
0.6
3.8
15.5
11.0
4.3
8.1
12.1
0
11.9
17.0
6.7
0
0
0
0
6.3
12.1
3.0
2.1
11.2
3.4
3.9
0
0.4
11.3
5.3
Female
2.6
12.7
18.1
3.3
0
1.9
15.2
2.0
6.0
5.4
12.0
4.5
2.8
3.2
90.9
0
42.2
6.6
0
0
0
0
10.0
6.4
6.3
13.2
10.4
0
8.1
2.7
0.8
6.2
2.2
Total
(n)
7
7
26
3
0
4
7
5
49
5
92
19
5
5
1
6
12
53
0
0
0
0
19
5
22
10
68
8
6
1
3
62
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17.7% of children who died in 1984, and malignant disease
accounted for a further 9.7% of mortality.
Discussion
Completeness of the survey
The data in this paper are all derived from the patient ques-
tionnaires of 4983 individually registered paediatric
patients. Completeness of returns on paediatric patients
is difficult to judge because of the absence of an accepted
definition of a paediatric unit. On the 1984 centre
questionnaire, 97 centres defined themselves as specialised
paediatric units. There are a great many more which are
known to treat children but did not define themselves as
specialised. Ascertainment of whether a unit treats children
or not depends upon return of patient questionnaires. It
is therefore not possible to calculate what coverage of
paediatric patients the Registry achieves because there is no
denominator. The only information that is readily available
is that the 97 centres which define themselves as specialised
paediatric units all returned patient questionnaires in 1984.
Trends in renal replacement therapy
At the close of 1984 there were 1570 individually registered
children alive on all methods of renal replacement therapy.
There were a further 1835 who had commenced treatment
under the age of 15 but at the end of 1984 were aged more
than 15 years. This represents an increase of 26% over the
stock of paediatric patients registered alive at the end of
1983. In 1984, 522 children commenced renal replacement
therapy throughout Europe. The acceptance rate per
million child population varied greatly from country to
country (Tables 4 and 5 of the preceding report). Overall,
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Table 4. Grafts reported to the Registry in children in 1984 by individual country. Grafts are shown according to source
and number in overall graft sequence
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< 'ountry
Algeria
Austria
Belgium
Bulgaria
Cyprus
('zechoslavakia
Denmark
•-gypt
Ted. Rep. Germany
1 inland
Trance
(icrman Dem. Rep.
(ireece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Live donor
1st
0
1
15
0
0
0
2
4
2
1
3
0
1
0
0
6
2
4
0
0
1
0
1
2
1
0
8
5
0
0
0
6
2
2nd
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
3rd
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
o"0
0
0
0
0
Total
0
1
15
0
0
0
2
4
2
1
4
0
1
0
0
6
2
4
0
0
1
0
1
2
1
0
9
5
0
0
0
6
2
Cadaver
1st
0
3
7
0
0
2
6
0
27
4
50
6
0
3
0
1
2
12
0
0
1
0
15
2
2
1
30
1
6
0
0
43
0
2nd
0
0
2
0
0
1
2
0
8
0
6
0
0
1
0
1
0
2
0
0
0
0
0
2
0
0
6
0
1
0
0
17
0
3rd
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
Total
0
3
10
0
0
3
8
0
35
4
56
6
0
4
0
2
2
14
0
0
1
0
15
4
2
1
38
1
7
0
0
60
0
All
grafts
0
5
25
0
0
3
10
4
37
5
63
7
1
4
0
8
5
18
0
0
2
0
16
6
4
1
47
6
7
0
0
67
2
acceptance rates of children were highest in those aged
10-14 at first therapy. The highest acceptance rate for
paediatric patients in 1984 was recorded in Belgium, where
26 children commenced therapy in total. The age specific
acceptance rates for male children aged under 5 reached 8.4
in the Netherlands and 7.2 in Spain and Sweden. In 18 of 33
countries no children under the age of 5 were accepted for
replacement therapy in 1984.
Acceptance rates for male children aged between 5 and 9
at first therapy reached 11.8 in Ireland, compared with 14.4
in Sweden for females of the same age group. In Belgium,
the age specific acceptance rate for male children aged
10-14 reached 29.7 and for females, 18.1. The highest
acceptance rate for females in this age category was
reported in Iceland but this represented only one patient.
Primary renal diseases
Information on primary renal diseases leading to end-stage
renal failure was provided in 496 of 522 paediatric patients
who commenced therapy in 1984. These diseases were ana-
lysed according to age at start of treatment and interesting
differences noted. The proportion of children reported with a
diagnosis of chronic renal failure, aetiology uncertain,
declined with increasing age at start of treatment, from 9.3%
of children commencing therapy under 5 years to 4.7%
among those who started treatment between 10 and 14 years
of age. Haemolytic uraemic syndrome was the primary renal
disease reported in 12.0% of children starting treatment
under 5 and 12.3% of those aged between 5 and 9. Among
children aged 10-14, it was reported in less than 1 % of cases.
Causes of death
In children, as in adults, the leading causes of death are
cardiac, accounting for 46.8% of deaths in children on renal
replacement therapy in 1984. Vascular causes of death are
less important than in adults and no deaths from liver disease
were reported in children in 1984. The proportion of deaths
in children defined as uncertain, not determined or
unknown, is very similar to that reported in adults.
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Table 5. Proportional distribution (%) of causes of end-stage renal failure in children starting renal replacement therapy in 1984
according to age at start of therapy
Causes of end-stage renal failure Age at start treatment 1984 (%)
0-4
9.3
12.0
18.7
4.0
0
8.0
0
0
0
0
0
0
0
2.7
0
8.0
14.7
1.3
0
0
0
1.3
0
0
0
0
1.3
0
0
0
0
0
0
12.0
0
0
1.3
0
1.3
0
1.3
0
2.6
5-9 .
5.7
3.3
13.9
4.9
3.3
17.2
0
4.1
0
0
0
0
0.8
0
0.8
7.4
9.9
0
4.1
2.5
2.4
0
0
0
0
0.8
0
0
0
0
0.8
0
0
12.3
0.8
0.8
0
0
0.8
0
0.8
0.8
1.6
10-14
4.7
8.4
24.0
4.3
2.7
13.0
0.7
8.4
0.7
0
0.3
0
0
0.3
1.3
6.7
10.4
2.0
1.3
0.7
0
0
0.3
0
0
0.7
0
0
0
1.3
3.3
0
0
0.7
0.3
0.3
0
0
1.0
0
0.3
0
1.7
Chronic renal failure, aetiology uncertain
Glomerulonephritis—histologically not examined
—histologically examined
Pyelonephritis/interstitial nephritis—cause not specified
—associated with neurogenic bladder
—due to congenital obstructive uropathy with or without vesico-ureteric reflux
—due to acquired obstructive uropathy
—due to vesico-ureteric reflux without obstruction
—due to urolithiasis
—due to other cause
Nephropathy—caused by drugs or nephrotoxic agents—cause not specified
—due to analgesic drugs
Cystic kidney disease—type unspecified
Polycystic kidneys—adult type
—infantile and juvenile types
Medullary cystic disease, including nephronophthisis
Hereditary/familial nephropathy
Hereditary nephritis with nerve deafness (Alport's syndrome)
Cystinosis
Oxalosis
Renal vascular disease—type unspecified
—due to malignant hypertension (no primary renal disease)
—due to hypertension (no primary renal disease)
—due to polyarteritis
Wegener's granulomatosis
Diabetes—insulin dependent (type I)
—non-insulin dependent (type II)
Myelomatosis
Amyloid
Lupus erythematosus
Henoch-Schonlein purpura
Goodpasture's syndrome
Scleroderma
Haemolytic uraemic syndrome (Moschcowitz syndrome)
Multisystem disease—other
Cortical or tubular necrosis
Tuberculosis
Gout
Nephrocalcinosis and hypercalcaemic nephropathy
Balkan nephropathy
Kidney tumour
Traumatic or surgical loss of kidney
Other identified renal disorders
Total patients with diagnosis available 75 122 299
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Table 6. Proportional distribution of causes of death in children dying in 1984. Absolute numbers are also given
Causes of death on renal replacement therapy
Cause of death i
Cardiac:
Vascular:
Infection:
Liver disease:
Gastro-intestina
Social:
Miscellaneous:
Accident:
incertain/not determined/unknown
Myocardial ischaemia and infarction
Hyperkalaemia
Haemorrhagic pericarditis
Other causes of cardiac failure
Cardiac arrest, cause unknown
Hypertensive cardiac failure
Hypokalaemia
Fluid overload
Pulmonary embolus
Cerebrovascular accident
Haemorrhage from graft site
Haemorrhage from vascular access or dialysis circuit
Haemorrhage from ruptured vascular aneurysm
Haemorrhage from surgery
Other haemorrhage
Pulmonary infection (bacterial)
Pulmonary infection (viral)
Pulmonary infection (fungal)
Infections elsewhere
Septicaemia
Tuberculosis
Generalized viral infection
Peritonitis
Viral hepatitis
Drug toxicity
Cirrhosis—not viral
Cystic liver disease
Liver failure—cause unknown
1: Gastro-inteslinal haemorrhage
Mesenteric infarction
Pancreatitis
Sclerosing (or adhesive) peritoneal disease
Perforation of peptic ulcer
Perforation of colon
Patient refused further treatment
Suicide
Therapy ceased for any other reason
Uraemia caused by graft failure
Bone marrow depression
Cachexia
Malignant disease
Dementia
Accident related to treatment
Accident unrelated to treatment
Other identified cause of death
Total patients with known cause of death
Deaths under
Total (n)
4
0
3
2
4
9
4
0
7
0
2
0
0
0
0
1
4
0
0
0
3
0
2
2
0
0
0
0
0
0
0
1
0
1
0
0
0
2
0
0
1
6
0
0
0
4
62
15 years, 1984
Percent (%)
6.5
0
4.8
3.2
6.5
14.5
6.5
0
11.3
0
3.2
0
0
0
0
1.6
6.5
0
0
0
4.8
0
3.2
3.2
0
0
0
0
0
0
0
1.6
0
1.6
0
0
0
3.2
0
0
1.6
9.7
0
0
0
6.5
100
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